Top Gear
22 Dec 2020
Trial Summary
Trial of Preoperative Therapy for Gastric and Esophagogastric Junction Adenocarcinoma: A randomised phase II/III trial of preoperative chemoradiotherapy versus preoperative chemotherapy for resectable gastric cancer.
Acronym:
Top Gear
ACTRN/NCT /ethics:
ACTRN12609000035224 NCT01924819
Scientific title:
A Randomised Phase II/III Trial of Preoperative Chemoradiotherapy Versus Preoperative Chemotherapy for Resectable Gastric Cancer
Sponsor / Cooperative group:
Australasian Gastro-Intestinal Trails Group
Trial & Patient Characteristics
| Cancer Type | Stomach & Oesophageal |
|---|---|
| Trial Type | Treatment |
| Phase | Phase III |
| Age Range | 18 years and older |
| Sex | Both |
| Tumour Stream | - |
| Cancer Stage | All stages |
| Anticipated Start Date | 2009-09-01 |
| Anticipated End Date | 2020-12-01 |
Participating Hospitals
| Hospital | Flinders Medical Centre |
|---|---|
| Clinical Trial Coordinator | Alex Scott-Hoy |
| alex.scott-hoy@sa.gov.au | |
| Phone | 08 8204 4830 |
| Principal Investigator | Dr Chris Karapetis |
| Recruitment Status | Recruiting |